RNA actuator therapeutic for hereditary angioedema(CAMP4 Therapeutics)

N/A

Report date: 2025/01/26 18:02:06
NME

Base Information

Drug NameRNA actuator therapeutic for hereditary angioedema(CAMP4 Therapeutics)
Drug Alias Nameantisense oligonucleotide for hereditary angioedema(CAMP4 Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionPlasma protease C1 inhibitor gene transference
TargetsPlasma protease C1 inhibitor
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCamp4 Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCamp4 Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A